22157.jpg
CDK9 inhibitor Drug Pipeline Research Report 2024
April 12, 2024 07:29 ET | Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "CDK9 inhibitor - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering."Cyclin-Dependent Kinase 9 (CDK9)...
Global Antibody Therapeutics Market
Antibody Therapeutics (Monoclonal, Polyclonal, Antibody Fragment, Bispecific) Market Research 2023: Advancements in Antibody Engineering and Growing Focus on Collaborations for Drug Discovery
April 04, 2024 04:12 ET | Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune &...
22157.jpg
COSENTYX (Secukinumab) Market Analysis and Outlook 2019-2032: Mechanism, Dosage, Research, Sales, Regulatory Milestones, Patents, SWOT Analysis
April 02, 2024 11:47 ET | Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "COSENTYX Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
Monoclonal Antibodies in Veterinary Health: Global and Regional Market Analysis by Animal Type, Application, End User, and Country - Forecast to 2033
March 18, 2024 05:49 ET | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies in Veterinary Health Market: Focus on Animal Type, Application, and End User, Regional Analysis, and Competitive...
Global Therapeutic Antibody Market
Global Therapeutic Antibody Market Research, 2019-2023 and 2024-2029
February 27, 2024 10:04 ET | Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human,...
Dyadic Logo Current.jpg
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
February 21, 2024 08:30 ET | Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...
22157.jpg
Downstream Processing Market Report 2024: Global Trends and Competitive Analysis to 2030 Featuring Thermo Fisher Scientific, GE Healthcare, Sartorius, Merck Millipore, Danaher, and 3M Among Others
February 21, 2024 06:37 ET | Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Downstream Processing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global IL-17 Biologics Market
Global IL-17 Biologics Research Report 2023-2030: A $4.37 Billion Market in 2022 - Advancements in Monoclonal Antibody Engineering Fuel Development of Targeted IL-17 Biologics
February 20, 2024 10:57 ET | Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By...
Dyadic Logo Current.jpg
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
February 13, 2024 08:30 ET | Dyadic International, Inc.
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...
Global Biologic Therapeutic Drugs Markets
Biologic Therapeutic Drugs Market Analysis Reveals Robust Growth Projections Through 2028, Discloses Technologies and Global Markets Insights
February 09, 2024 04:16 ET | Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Biologic Therapeutic Drugs: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The biologics market is...